Medical economics

What will it take to boost Africa's vaccine production?

The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.

Diseases, Conditions, Syndromes

JYNNEOS vaccination provides protection against mpox

Among men aged 18 to 49 years who are eligible for the JYNNEOS vaccine, mpox incidence is considerably higher among unvaccinated persons versus those who received one or two vaccine doses, according to research published ...

page 5 from 27